Elsevier

Annals of Vascular Surgery

Volume 34, July 2016, Pages 280-289
Annals of Vascular Surgery

General Review
A Systematic Review of the Uptake and Adherence Rates to Supervised Exercise Programs in Patients with Intermittent Claudication

https://doi.org/10.1016/j.avsg.2016.02.009Get rights and content

Background

Intermittent claudication (IC) is a common and debilitating symptom of peripheral arterial disease and is associated with a significant reduction in a sufferer's quality of life. Guidelines recommend a supervised exercise program (SEP) as the primary treatment option; however, anecdotally there is a low participation rate for exercise in this group of patients. We undertook a systematic review of the uptake and adherence rates to SEPs for individuals with IC.

Methods

The MEDLINE, Embase, and PubMed databases were searched up to January 2015 for terms related to supervised exercise in peripheral arterial disease. The review had 3 aims: first, to establish the rates of uptake to SEPs, second, the rates of adherence to programs, and finally to determine the reasons reported for poor uptake and adherence. Separate inclusion and/or exclusion criteria were applied in selecting reports for each aim of the review.

Results

Only 23 of the 53 potentially eligible articles for uptake analysis identified on literature searches reported any details of screened patients (n = 7,517) with only 24.2% of patients subsequently recruited to SEPs. Forty-five percent of screen failures had no reason for exclusion reported. Sixty-seven articles with 4,012 patients were included for analysis of SEP adherence. Overall, 75.1% of patients reportedly completed an SEP; however, only one article defined a minimal attendance required for SEP completion. Overall, 54.1% of incomplete adherence was due to patient withdrawal and no reason for incomplete adherence was reported for 16% of cases.

Conclusions

Reporting of SEP trials was poor with regard to the numbers of subjects screened and reasons for exclusions. Only approximately 1 in 3 screened IC patients was suitable for and willing to undertake SEP. Levels of adherence to SEPs and definitions of satisfactory adherence were also lacking in most the current literature. Current clinical guidelines based on this evidence base may not be applicable to most IC patients and changes to SEPs may be needed to encourage and/or retain participants.

Introduction

Intermittent claudication (IC) is the most common symptom of peripheral arterial disease (PAD), affecting 5% of the population over the age of 50 years1 and 20% of the population over 70 years.2 IC is due to muscle ischemia precipitated by exercise and is frequently associated with a reduction in walking capabilities.3 Supervised exercise programs (SEPs) for patients with claudication have been demonstrated to improve walking distances and be cost effective.4 Current clinical guidelines recommend that all patients with IC are enrolled on a group-based SEP.5, 6 Furthermore, centers should consider a program comprised intermittent walking to near maximal or maximal pain, 3 times a week, for a minimum of 12 weeks.7

Although it is agreed that supervised exercise should be the first-line treatment, there is evidence suggesting that relatively few patients are suitable for and will agree to participation in an SEP.8 Many who commence an SEP fail to complete the program of classes. Clearly, the clinical and cost effectiveness of SEPs for managing the population of IC patients as a whole may be significantly affected by poor recruitment and adherence to programs.

This review has 3 aims, first, to establish from the existing literature the levels of uptake of SEPs in published trials, which we defined as the proportion of screened patients who went on to commence an SEP. Second, to determine patient adherence to SEPs, which was defined as the proportion of patients who commenced an SEP and subsequently completed all sessions. Third, to explore what reasons were reported for lack of uptake or adherence in IC patients.

Section snippets

Methods

A systematic review of randomized clinical trial (RCT) and nonrandomized clinical trials including an SEP arm was performed. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used for reporting of search results.9

Search Results

The search yielded a total of 333 reports of which 11 were duplicates. Of the remaining 322, 67 were appropriate for inclusion in one or both sections of the planned analysis. The inclusion and/or exclusion process is summarized in Figure 1.

Included Trials

Our analysis included 67 trials, all of which used some form of SEP in claudicants and recorded details of recruited subjects and numbers of those who commenced and completed an SEP. Fifty-two reports were from randomized trials and the remainder were

Discussion

SEPs have been shown to be both clinically and cost effective in treatment of IC, and there is a wealth of evidence supporting the recommendation of SEP as the first-line treatment for IC. However, the results of this review suggest that this evidence may not be universally applicable to the IC population as a whole.

Most trials included in this review gave no indication of numbers of IC patients screened for inclusion which makes the application of their results difficult. Where screening

Conclusions

Details of populations screened, reasons for exclusion, and definitions of adequate uptake and adherence were lacking in most reports. Where data was reported, only 1 in 3 patients screened were suitable for and willing to undertake SEP. This has potential implications for the recommendation of SEP as first-line treatment for all IC patients as there may be a significant proportion of patients where SEP treatment is not accepted or possible. Future reports regarding SEP trials need to include

References (76)

  • S.D. Hobbs et al.

    The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication: a randomized controlled trial

    J Vasc Surg

    (2007)
  • R. Januszek et al.

    The effect of treadmill training on endothelial function and walking abilities in patients with peripheral arterial disease

    J Cardiol

    (2014)
  • S.K. Kakkos et al.

    Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial

    Eur J Vasc Endovasc Surg

    (2005)
  • S. King et al.

    The effect of a 3-month supervised exercise programme on gait parameters of patients with peripheral arterial disease and intermittent claudication

    Clin Biomech

    (2012)
  • L.M. Kruidenier et al.

    Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomized clinical trial

    J Vasc Interv Radiol

    (2011)
  • L.M. Kruidenier et al.

    Supervised exercise therapy for intermittent claudication in daily practice

    J Vasc Surg

    (2009)
  • A.S. Leicht et al.

    Influence of peripheral arterial disease and supervised walking on heart rate variability

    J Vasc Surg

    (2011)
  • A.L. Meneses et al.

    Impact of a supervised strength training or walking training over a subsequent unsupervised therapy period on walking capacity in patients with claudication

    J Vasc Nurs

    (2011)
  • S.P. Nicolai et al.

    Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication

    J Vasc Surg

    (2010)
  • J.G. Regensteiner et al.

    Exercise training improves functional status in patients with peripheral arterial disease

    J Vasc Surg

    (1996)
  • O. Schlager et al.

    Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: a randomized controlled trial

    Atherosclerosis

    (2011)
  • K.M. van Pul et al.

    Effect of supervised exercise therapy for intermittent claudication in patients with diabetes mellitus

    Ann Vasc Surg

    (2012)
  • B. Versluis et al.

    Magnetic resonance imaging-based monitoring of collateral artery development in patients with intermittent claudication during supervised exercise therapy

    J Vasc Surg

    (2013)
  • R.D. Walker et al.

    Influence of upper- and lower-limb exercise training on cardiovascular function and walking distances in patients with intermittent claudication

    J Vasc Surg

    (2000)
  • I. Zwierska et al.

    Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial

    J Vasc Surg

    (2005)
  • M.A. Popplewell et al.

    Why do health systems not fund supervised exercise programmes for intermittent claudication?

    Eur J Vasc Endovasc Surg

    (2014)
  • L. Norgren et al.

    Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

    J Vasc Surg

    (2007)
  • B.J. Parmenter et al.

    A systematic review of randomized controlled trials: Walking versus alternative exercise prescription as treatment for intermittent claudication

    Atherosclerosis

    (2011)
  • W. Al-Jundi et al.

    Systematic review of home-based exercise programmes for individuals with intermittent claudication

    Eur J Vasc Endovasc Surg

    (2013)
  • L.N. Gommans et al.

    Editor's choice–The effect of supervision on walking distance in patients with intermittent claudication: a meta-analysis

    Eur J Vasc Endovasc Surg

    (2014)
  • A. Szuba et al.

    Limb hemodynamics are not predictive of functional capacity in patients with PAD

    Vasc Med

    (2006)
  • E. Selvin et al.

    Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000

    Circulation

    (2004)
  • H.G. Beebe

    Intermittent claudication: effective medical management of a common circulatory problem

    Am J Cardiol

    (2001)
  • L. Watson et al.

    Exercise for intermittent claudication

    Cochrane Database Syst Rev

    (2008)
  • B.L. Bendermacher et al.

    Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication

    Cochrane Database Syst Rev

    (2006)
  • A.T. Hirsch et al.

    ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)–summary of recommendations

    J Vasc Interv Radiol

    (2006)
  • U. Muller-Buhl et al.

    Low attendance of patients with intermittent claudication in a German community-based walking exercise program

    Int Angiol

    (2012)
  • A. Liberati et al.

    The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

    BMJ

    (2009)
  • Cited by (141)

    View all citing articles on Scopus

    Funding: Miss Harwood is funded by a University of Hull PhD scholarship.

    View full text